Cold-inducible RNA binding protein (CIRP) in human cancers is reviewed, where it has been implicated in tumor suppression and promotion.
Cover Art – Biomaterials, Cancer Nanomedicine and Macroporous Hydrogels
Latest Advanced Healthcare Materials covers.
A Potent Magnetic Fluid Hyperthermia Agent for Cancer Treatment
Researchers develop a new anticancer agent composed of magnesium shallow-doped iron oxide superparamagnetic nanoparticles (SPNPs). The magnetic fluid hyperthermia (MNFH) agent is highly biocompatible and is able to completely eradicate Hep3B-induced tumors.
Cancer Invasion Rate Modulated by Microenvironment Stiffness
An approach to study tumor cell invasiveness by exploiting an innovative class of polymeric scaffolds based on two-photon lithography to control the stiffness of deterministic microenvironments in 3D is presented.
Multimodal Agent for Cancer Diagnostics and Therapeutics
Chunmeng Shi and co-workers from the Third Military Medical University in Chongqing, China, introduce a small-molecule-based cancer theranostic agent for simultaneous cancer-cell mitochondrial targeting, NIR imaging, and chemo-/PDT/PTT/multimodal therapeutic activities.
Ancient and Modern Hints: Chemotherapy Resistance in Ovarian Cancer
RNA-binding proteins influence epithelial ovarian cancer progression through complex networks with mRNAs, non-coding RNAs and other proteins.
Molecular Therapeutics for Drug-Free Cancer Treatment
Drug-free macromolecular therapeutic systems can target and kill cancer cells without causing the side-effects of the drugs currently in clinical use.
Drug Nanocrystals for Cancer Therapy
Drug nanocrystals deliver drugs via oral, intravenous, and local administration and show promise towards treating cancer more effectively.
Cancer Therapy with Magnetic RNA Interference Nanoparticles
A team of researchers from National Sun Yat-sen University report on microscale RNA interference using iron oxide nanoparticle-modified lentivirus.
Cancer Reports – New Broad Scope Journal for Cancer Research
A new broad scope journal dedicated to publishing data-driven, scientifically rigorous findings at every stage of basic, translational, clinical and interdisciplinary research in cancer development, progression, treatment, care and outcome.